Placebo-controlled trial of cytisine for smoking cessation.
BACKGROUND: Cytisine, a partial agonist that binds with high affinity to the α(4)β(2) nicotinic acetylcholine receptor, is a low-cost treatment that may be effective in aiding smoking cessation. This study assessed the efficacy and safety of cytisine as compared with placebo. METHODS: We conducted a...
Glavni autori: | West, R, Zatonski, W, Cedzynska, M, Lewandowska, D, Pazik, J, Aveyard, P, Stapleton, J |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
2011
|
Slični predmeti
-
Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine
od: Aveyard, P, i dr.
Izdano: (2009) -
Cytisine and the failure to market and regulate for human health.
od: Aveyard, P, i dr.
Izdano: (2013) -
Potential uses of cytisine for smoking cessation in menopausal women – literature summary
od: Francisco Rubio Rubio, i dr.
Izdano: (2023-04-01) -
Cytisine versus varenicline for smoking cessation in a primary care setting: a randomized non-inferiority trial
od: Oreskovic, T, i dr.
Izdano: (2023) -
Cancer and smoking cessation
od: Magdalena Cedzynska, i dr.
Izdano: (2019-10-01)